Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
35.02
-0.66 (-1.85%)
May 28, 2026, 3:04 PM CST
SHE:002422 Revenue
Sichuan Kelun Pharmaceutical had revenue of 4.26B CNY in the quarter ending March 31, 2026, a decrease of -2.98%. This brings the company's revenue in the last twelve months to 18.38B, down -8.01% year-over-year. In the year 2025, Sichuan Kelun Pharmaceutical had annual revenue of 18.51B, down -15.13%.
Revenue (ttm)
18.38B
Revenue Growth
-8.01%
P/S Ratio
3.03
Revenue / Employee
913.31K
Employees
20,127
Market Cap
55.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 18.51B | -3.30B | -15.13% |
| Dec 31, 2024 | 21.81B | 358.49M | 1.67% |
| Dec 31, 2023 | 21.45B | 2.42B | 12.69% |
| Jan 1, 2023 | 19.04B | 1.76B | 10.19% |
| Jan 1, 2022 | 17.28B | 813.21M | 4.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 54.56B |
| Zhejiang Int'l Group | 33.84B |
| Zhangzhou Pientzehuang Pharmaceutical. | 8.60B |
| Yifan Pharmaceutical | 5.06B |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 3.11B |
| GuangYuYuan Chinese Herbal Medicine | 1.44B |
| Zhejiang Wolwo Bio-Pharmaceutical | 1.09B |
| Shanghai InnoStar Bio-tech | 812.23M |
Sichuan Kelun Pharmaceutical News
- 4 weeks ago - Sichuan Kelun Pharmaceutical Quarterly report: Q1 2026 - Filings
- 2 months ago - Sichuan Kelun Pharmaceutical Earnings Call Transcript: H2 2025 - Transcripts
- 2 months ago - Sichuan Kelun Pharmaceutical Annual report: H2 2025 - Filings
- 4 months ago - Sichuan Kelun Pharmaceutical Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 6 months ago - Crescent, Kelun-Biotech Sign Oncology Deal; Crescent To Raise $185 Mln; Stock Up - Nasdaq
- 7 months ago - Sichuan Kelun Pharmaceutical Quarterly report: Q3 2025 - Filings
- 10 months ago - Sichuan Kelun Pharmaceutical Earnings Call Transcript: H1 2025 - Transcripts
- 10 months ago - Sichuan Kelun Pharmaceutical Quarterly report: H1 2025 - Filings